Federal Data Hub › HRSA 340B · JSON
340B ID CAH251318-00
ParticipatingCritical Access Hospital
NORTH SUNFLOWER MEDICAL CENTER is a Critical Access Hospital enrolled in the federal 340B Drug Pricing Program in RULEVILLE, MS. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 20 contract-pharmacy arrangement(s) (18 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| CVS CAREMARK | WILKES BARRE, PA | 2025-07-01 | — | 25050 |
| CVS CAREMARK ADVANCED TECHNOLOGY PHARMAC | MT PROSPECT, IL | 2025-07-01 | — | 59114 |
| MISSISSIPPI CVS PHARMACY, L.L.C. | GREENWOOD, MS | 2025-07-01 | — | 46513 |
| NORTH SUNFLOWER MEDICAL CENTER | RULEVILLE, MS | 2015-10-01 | 2021-04-13 | 98450 |
| OPTUM PHARMACY 701, LLC | FLINT, MI | 2023-01-01 | — | 132743 |
| OPTUM PHARMACY 702, LLC | JEFFERSONVILLE, IN | 2023-01-01 | — | 90281 |
| OPTUM PHARMACY 704, INC. | SAN ANTONIO, TX | 2023-01-01 | — | 71775 |
| OPTUM PHARMACY 705, LLC | BIRMINGHAM, AL | 2023-01-01 | — | 43586 |
| OPTUM PHARMACY 801, INC. | PHOENIX, AZ | 2023-01-01 | 2026-04-21 | 119478 |
| OPTUMRX | OVERLAND PARK, KS | 2023-01-01 | — | 62851 |
| WAL-MART CENTRAL FILL 10-2670 | SPRING, TX | 2021-07-01 | — | 70688 |
| WAL-MART PHARMACY 10-0716 | GREENWOOD, MS | 2025-07-01 | — | 46514 |
| WAL-MART PHARMACY 10-1530 | CLEVELAND, MS | 2021-07-01 | — | 46384 |
| WAL-MART PHARMACY 10-5315 | ORLANDO, FL | 2022-01-01 | — | 39265 |
| WAL-MART PHARMACY 10-5997 | ORLANDO, FL | 2021-07-01 | — | 39270 |
| WALGREEN CO. | CLEVELAND, MS | 2021-07-01 | — | 3960 |
| WALGREEN CO. | GREENWOOD, MS | 2021-07-01 | — | 2597 |
| WALMART PHARMACY 10-5169 | ROGERS, AR | 2023-07-01 | — | 66076 |
| Walgreens #21389 | Memphis, TN | 2025-07-01 | — | 134120 |
| Walmart Pharmacy 10-7611 | Plainfield, IN | 2024-01-01 | — | 140224 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.